SpringWorks Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

SpringWorks Therapeutics

03/05/2023 13:27

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of $1.18​​ per share for the quarter ended in
March. The mean expectation of six analysts for the quarter was
for a loss of $1.25 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of $1.18​.
    * The mean earnings estimate of analysts had fallen by
about 6.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * SpringWorks Therapeutics Inc shares had fallen by 9.4%
this
quarter and lost 10.3% so far this year.
    * The company reported a quarterly loss of $73.42 million.
    * Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
3 at 12:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.25          -1.18          Beat
 Dec. 31 2022      -1.22          -1.17          Beat
 Sep. 30 2022      -1.32          -1.37          Missed
 Jun. 30 2022      -1.20          -1.41          Missed